Atlas Endoscopy key facts
as of Nov 2026- Developer of a robotic colonoscopy system designed to democratize access to colonoscopy procedures.
- Atlas Endoscopy is valued at approximately $12.3M as of Nov 2026 (last reported valuation).
- It has raised $1.9M; the latest was Early Stage VC ($1.1M) in Sep 2025.
- Notable investors include Vanderbilt University, Deepbridge Capital.
- Status: Privately Held (backing).
Atlas Endoscopy's last reported valuation, Sep 2025. Nothing priced has surfaced since.
Atlas Endoscopy funding rounds
No funding rounds for Atlas Endoscopy are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Atlas Endoscopy
2Atlas Endoscopy valuation
Atlas Endoscopy's last reported valuation was $12.3 million in Sep 2025. No priced round, secondary trade or fund mark has surfaced since.
Atlas Endoscopy investors
2 investors are on record for Atlas Endoscopy, including Vanderbilt University and Deepbridge Capital.
About Atlas Endoscopy
Developer of a robotic colonoscopy system designed to democratize access to colonoscopy procedures. The company develops advanced endoscopic technology that offers a higher standard of care for patients and precision tools for endoscopists, enabling clients to enhance healthcare capacity and improve patient outcomes.
- Sector
- Healthcare
- HQ
- Leeds, United Kingdom
- Founded
- 2021
- Employees
- 17
- Website
- atlasendoscopy.org/
- Ownership
- Privately Held (backing)
Is this your company? Profiles are maintained at PrivateMarketView, the data platform behind this page — sign in with your work email to keep it current, or tell us what's wrong.